Likewise, mutations in BRCA1, BRCA2, PALB2, and other components with the HR pathway are common in familial and certain subtypes of sporadic breast cancer, particularly triple negative breast cancer (91–, 93). The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.